share_log

Black Diamond Therapeutic Q3 EPS $(0.45) Beats $(0.46) Estimate; Cash, Cash Equivalents, And Investments Of $144.3M, Expected To Be Sufficient To Fund Operations Into 1H Of 2025

Benzinga ·  Nov 6, 2023 07:17

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 25 percent increase over losses of $(0.60) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment